4
Changes in Ownership
Acumen Pharmaceuticals, Inc. Filed Acc 0001209191-23-000327
CFO and Chief Business Officer acquired 50,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Zuga Matt CFO and Chief Business Officer | 2022-12-29 | Option exercise | +50,000 | $1.19 | $59,500 | 76,187 | D |
| Derivatives | |||||||
| Zuga Matt CFO and Chief Business Officer | 2022-12-29 | Option exercise · Stock Option (right to buy) | −50,000 | 401,369 | D | ||
Loading xslF345X03/doc4.xml…